Effect of Salusin-β on Peroxisome Proliferator-Activated Receptor Gamma Gene Expression in Vascular Smooth Muscle Cells and its Possible Mechanism

被引:12
|
作者
Xu, XiaoLe [1 ,2 ]
He, Mengzi [1 ,2 ]
Liu, Tingting [1 ,2 ]
Zeng, Yi [1 ,2 ]
Zhang, Wei [1 ,2 ]
机构
[1] Nantong Univ, Coll Pharm, Dept Pharmacol, Nantong 226001, Peoples R China
[2] Key Lab Inflammat & Mol Drug Target, Nantong, Peoples R China
基金
美国国家科学基金会;
关键词
Salusin-beta; Smooth muscle cells; Signal transduction; Vascular biology; KAPPA-B-ALPHA; GROWTH-FACTOR-BETA; PPAR-GAMMA; ANGIOTENSIN-II; INHIBITION; ATHEROSCLEROSIS; CONTRIBUTES; BINDING;
D O I
10.1159/000430207
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: salusin-beta is considered to be a potential pro-atherosclerotic factor. Regulation and function of vascular smooth muscle cells (VSMCs) are important in the progression of atherosclerosis. Peroxisome proliferator-activated receptor gamma (PPAR gamma) exerts a vascular protective role beyond its metabolic effects. Salusin-beta has direct effects on VSMCs. The aim of the present study was to assess the effect of salusin-beta on PPAR gamma gene expression in primary cultured rat VSMCs. Methods: Western blotting analysis, real-time PCR and transient transfection approach were used to determine expression of target proteins. Specific protein knockdown was performed with siRNA transfection. Cell proliferation was determined by 5-bromo-2'-deoxyuridine incorporation. The levels of inflammation indicators interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) were determined using enzyme-linked immunosorbent assay. Results: Salusin-beta negatively regulated PPAR. gene expression at protein, mRNA and gene promoter level in VSMCs. The inhibitory effect of salusin-beta on PPAR gamma gene expression contributed to salusin-beta-induced VSMCs proliferation and inflammation in vitro. I kappa B alpha-NF-kappa B activation, but not NF-kappa B p50 or p65, mediated the salusin-beta-induced inhibition of PPAR gamma gene expression. Salusin-beta induced nuclear translocation of histone deacetylase 3 (HDAC3). HDAC3 siRNA prevented salusin-beta-induced PPAR gamma reduction. Nuclear translocation of HDAC3 in response to salusin-beta was significantly reversed by an I kappa B alpha inhibitor BAY 11-7085. Furthermore, I kappa B alpha-HDAC3 complex was present in the cytosol of VSMCs but interrupted after salusin-beta treatment. Conclusion: I kappa B alpha-HDAC3 pathway may contribute to salusin-beta-induced inhibition of PPAR gamma gene expression in VSMCs. Copyright (C) 2015 S. Karger AG, Basel
引用
收藏
页码:2466 / 2479
页数:14
相关论文
共 50 条
  • [31] Peroxisome proliferator-activated receptor gamma overexpression suppresses proliferation of human colon cancer cells
    Tsukahara, Tamotsu
    Haniu, Hisao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 424 (03) : 524 - 529
  • [32] Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation
    Bijli, Kaiser M.
    Kleinhenz, Jennifer M.
    Murphy, Tamara C.
    Kang, Bum-Yong
    Adesina, Sherry E.
    Sutliff, Roy L.
    Hart, C. Michael
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 80 : 111 - 120
  • [33] Peroxisome proliferator-activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
    Fumery, Mathurin
    Speca, Silvia
    Langlois, Audrey
    Davila, Anne-Marie
    Dubuquoy, Caroline
    Grauso, Marta
    Mena, Anthony Martin
    Figeac, Martin
    Metzger, Daniel
    Rousseaux, Christel
    Colombel, Jean-Frederic
    Dubuquoy, Laurent
    Desreumaux, Pierre
    Bertin, Benjamin
    EMBO MOLECULAR MEDICINE, 2017, 9 (11) : 1471 - 1481
  • [34] Peroxisome Proliferator-Activated Receptor-Gamma Expression in the Lung Tissue of Obese Rats
    Hwang, Su Jin
    Kim, Jung Ho
    Shim, Jae Won
    Kim, Duk Soo
    Jung, Hye Lim
    Park, Moon Soo
    Lee, Won Young
    Kim, Se-Yeon
    Shim, Jung Yeon
    YONSEI MEDICAL JOURNAL, 2011, 52 (03) : 495 - 501
  • [35] Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases
    Sharma, Vinesh
    Patial, Vikram
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma
    Takeuchi, Akihiko
    Yamamoto, Norio
    Shirai, Toshiharu
    Hayashi, Katsuhiro
    Miwa, Shinji
    Munesue, Seiichi
    Yamamoto, Yasuhiko
    Tsuchiya, Hiroyuki
    BMC CANCER, 2016, 16
  • [37] Expression of peroxisome proliferator-activated receptor gamma (PPAR-γ) in canine nasal carcinomas
    Paciello, O.
    Borzacchiello, G.
    Varricchio, E.
    Papparella, S.
    JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE, 2007, 54 (08): : 406 - 410
  • [38] Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with proliferative diabetic retinopathy
    Katome, Takashi
    Namekata, Kazuhiko
    Mitamura, Yoshinori
    Semba, Kentaro
    Egawa, Mariko
    Naito, Takeshi
    Harada, Chikako
    Harada, Takayuki
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (02) : 275 - 281
  • [39] Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells
    Pan, Guang-Dong
    Wu, Hong
    Liu, Jiang-Wen
    Cheng, Nan-Sheng
    Xiong, Xian-Ze
    Li, Sheng-Fu
    Zhang, Guo-Fu
    Yan, Lu-Nan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (38) : 6061 - 6065
  • [40] Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer
    Terashita, Y
    Sasaki, H
    Haruki, N
    Nishiwaki, T
    Ishiguro, H
    Shibata, Y
    Kudo, J
    Konishi, S
    Kato, J
    Koyama, H
    Kimura, M
    Sato, A
    Shinoda, N
    Kuwabara, Y
    Fujii, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (07) : 238 - 243